HEAL Initiative: Studies to Enable Analgesic Discovery (R61/R33 - Clinical Trial Not Allowed)
National Institutes of Health
Award ceiling
—Award floor
—Posted
Sep 18, 2024Closes
Jan 15, 2027Location eligibility
No specific state restriction found in this listing — check the full opportunity for details.Categories: Education, Food and Nutrition, Health, Income Security and Social Services
Eligible applicants: Nonprofits having a 501(c)(3) status with the IRS, other than institutions of higher education, Native American tribal organizations (other than Federally recognized tribal governments), County governments, Special district governments, Public housing authorities/Indian housing authorities, City or township governments, Independent school districts, Small businesses, Others (see text field entitled "Additional Information on Eligibility" for clarification), For profit organizations other than small businesses, Public and State controlled institutions of higher education, Private institutions of higher education, State governments, Native American tribal governments (Federally recognized), Nonprofits that do not have a 501(c)(3) status with the IRS, other than institutions of higher education
Description
This funding opportunity is part of a suite of NOFOs within the NIH HEAL Initiative to support the development of safe, effective, and non-addictive therapeutics to treat pain. The goal is to encourage initial translational efforts that will support a drug discovery program and advance projects to the point where they meet the entry criteria for the Pain Therapeutics Development Program. The scope will therefore be focused on development of assays to support a distinct testing funnel, screening efforts to identify hits, and initial characterization of hits and potential therapeutic agents (including small molecules, biologics, and natural products).